Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $206.0000 (-0.73%) ($205.8100 - $206.0000) on Wed. Sep. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.73% (three month average) | RSI | 75 | Latest Price | $206.0000(-0.73%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 1.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IGOV(26%) KWEB(20%) DRIV(19%) FXI(19%) VCSH(19%) | Factors Impacting SGEN price | SGEN will decline at least -0.365% in a week (0% probabilities). XOP(-21%) XLE(-19%) UUP(-17%) USO(-16%) UNG(-15%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.365% (StdDev 0.73%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $206.17(-0.08%) | 10 Day Moving Average | $206.46(-0.22%) | 20 Day Moving Average | $202.24(1.86%) | To recent high | -1% | To recent low | 7.5% | Market Cap | $35.816b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |